FDA

Oncology

Radiopharmaceutical development must move beyond fixed paradigms toward patient-specific, data-driven optimisation.

News

In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.

News

The FDA has cleared another generic of the abortion pill mifepristone, as it carries out a review of the drug that has been criticised as spurious.

News

The US government has shut down after Republicans and Democrats failed to resolve a budget standoff and the federal government ran out of money.

News

The Trump administration's linking of autism to Tylenol and vaccines with no evidence raises concern about an FDA review of mifepristone's safety.

Sales & Marketing

What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?